Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Reznik

Showing results (51-60 of 132) with videos related to

Pageof 14
Sort By:
Diabetes Care|September 22, 2009
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend studyDenis Raccah, Véronique Sulmont, Yves Reznik, et al.
Scientific Reports|August 24, 2025
Prospectively assessed hypothalamic-pituitary dysfunction after proton therapy in adults with head and neck, skull base and brain tumorsJordan Bouter, Nathan Azemar, Anthony Vela, et al.
The Journal of Clinical Endocrinology and Metabolism|September 21, 2006
McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patientsFrançoise Galland, Peter Kamenicky, Hélène Affres, et al.
Acta Diabetologica|August 10, 2014
Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot studyMichael Joubert, Laure Metayer, Gaetan Prevost, et al.
Diabetes, Obesity & Metabolism|January 22, 2024
The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetesYves Reznik, Elisabeth Bonnemaison, Guy Fagherazzi, et al.
Diabetes Technology & Therapeutics|May 31, 2018
Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR StudySylvie Picard, Hélène Hanaire, Yves Reznik, et al.
Diabetes Technology & Therapeutics|April 17, 2014
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methodsRonnie Aronson, Ohad Cohen, Ignacio Conget, et al.
Diabetes Technology & Therapeutics|January 25, 2017
Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit PatientsAntoine Clergeau, Jean-Jacques Parienti, Yves Reznik, et al.
Journal of the Endocrine Society|October 17, 2024
Plasma Renin: A Useful Marker for Mineralocorticoid Adjustment in Patients With Primary Adrenal InsufficiencyCécilia Piazzola, Bleunn Dreves, Frédérique Albarel, et al.
Clinical Endocrinology|February 21, 2008
Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive casesVirginie Médeau, François Moreau, Ludovic Trinquart, et al.
Pageof 14

Showing results (51-60 of 132) with videos related to

Sort By:
Pageof 14
Diabetes Care|September 22, 2009
Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend studyDenis Raccah, Véronique Sulmont, Yves Reznik, et al.
Scientific Reports|August 24, 2025
Prospectively assessed hypothalamic-pituitary dysfunction after proton therapy in adults with head and neck, skull base and brain tumorsJordan Bouter, Nathan Azemar, Anthony Vela, et al.
The Journal of Clinical Endocrinology and Metabolism|September 21, 2006
McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patientsFrançoise Galland, Peter Kamenicky, Hélène Affres, et al.
Acta Diabetologica|August 10, 2014
Neuromuscular electrostimulation and insulin sensitivity in patients with type 2 diabetes: the ELECTRODIAB pilot studyMichael Joubert, Laure Metayer, Gaetan Prevost, et al.
Diabetes, Obesity & Metabolism|January 22, 2024
The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetesYves Reznik, Elisabeth Bonnemaison, Guy Fagherazzi, et al.
Diabetes Technology & Therapeutics|May 31, 2018
Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR StudySylvie Picard, Hélène Hanaire, Yves Reznik, et al.
Diabetes Technology & Therapeutics|April 17, 2014
OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methodsRonnie Aronson, Ohad Cohen, Ignacio Conget, et al.
Diabetes Technology & Therapeutics|January 25, 2017
Impact of a Paper-Based Dynamic Insulin Infusion Protocol on Glycemic Variability, Time in Target, and Hypoglycemic Risk: A Stepped Wedge Trial in Medical Intensive Care Unit PatientsAntoine Clergeau, Jean-Jacques Parienti, Yves Reznik, et al.
Journal of the Endocrine Society|October 17, 2024
Plasma Renin: A Useful Marker for Mineralocorticoid Adjustment in Patients With Primary Adrenal InsufficiencyCécilia Piazzola, Bleunn Dreves, Frédérique Albarel, et al.
Clinical Endocrinology|February 21, 2008
Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive casesVirginie Médeau, François Moreau, Ludovic Trinquart, et al.
Pageof 14